This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Surgery for infective endocarditis

Authoring team

Situations where urgent surgical assessment should be undertaken include (1):

  • persistent pyrexia
  • persistently positive blood cultures
  • new murmurs
  • recurrent emboli despite maximal antimicrobial therapy
  • development of congestive cardiac failure - development of cardiac failure has a mortality of over 50% in patients with infective endocarditis managed with medical treatment alone (1)
  • large vegetations
  • persistent vegetation after a major systemic embolus
  • evidence of an intracardiac abscess
  • worsening renal failure may necessitate consideration of surgical intervention rather than continuation of medical therapy

Absolute indications for surgery include acute valvular regurgitation with pulmonary oedema, dehiscence of a prosthetic valve, and abscess formation (1).

Timing is critical. Ideally, infection should be eliminated beforehand but this has to be balanced against the risk of leaving the heart in a compromised haemodynamic state.

There is a 10 to 25% mortality for patients undergoing surgery during the acute phase.

Reference:

  1. Drugs and Therapeutics Bulletin (2002). 40 (4), 26-30.

Create an account to add page annotations

Add information to this page that would be handy to have on hand during a consultation, such as a web address or phone number. This information will always be displayed when you visit this page

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.